Catherine Falade, a consultant pharmacologist at the University College Hospital (UCH), Ibadan, says the first malaria vaccine still undergoing clinical trial is a major breakthrough in roll-back malaria programme.
The vaccine — RTS,S with trade name Mosquirix™ — is the first vaccine to sho
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
NAN
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
